of concern to health care workers, and presents information on the known toxicologic action and documented health effects in animal and human populations. The type of exposure and recommended protection for each exposure are outlined as well.
ANESTHETIC GASES
The most commonly used inhalation anesthetics in the United States are nitrous oxide, enflurane, halothane, and isoflurane. Approximately 50,000 health care workers are potentially exposed each year in operating room environments. Recently NIOSH (1994) issued a warning to thousands of medical, dental, and veterinary professionals who work with nitrous oxide (N20). Nitrous oxide is commonly used in hospitals as a carrier gas for the other, more potent anesthetics. In dental and outpatient offices, it is administered with oxygen, primarily as a sedative.
In the 1970s, nitrous oxide came under suspicion as a reproductive toxin because of studies linking exposure with birth defects and spontaneous abortion. Early studies of reproductive effect were often flawed, primarily because the lack of quantitative information on the nature of exposure, recall biases, response biases, and uncontrolled confounding.
(American Society of Anesthesiologists, 1974; Cohen, 1975) . Also, few studies look at confounding exposures such as radiation or methacrylate.
However, more recent studies have renewed concern about the potential. of N20 exposure and reproductive effects. Nitrous oxide inactivates vitamin B-12 resulting in interference with DNA production. Unlike any other anesthetic, N20 inactivates the enzyme methionine syntheses by oxidation of the cobalt component of the vitamin B-12 cofactor. Animal studies of rats exposed to 60% nitrous oxide for 24 hours on days 8 and 11 of pregnancy demonstrated increased fetal wastage and skeletal abnormalities (Fujinage, 1989) . A 1992 report published in the New England Journal of Medicine (Rowland, 1992) reported reduced fertility in female dental assistants exposed to nitrous oxide. Data were collected on exposure to nitrous oxide and the number of menstrual cycles without contraception required to become pregnant (n=459). In subjects working in an environment with no scavenger system and having greater than 5 hours of exposure per week, 42% required more than a year to conceive, compared with 11% of the nonexposed women.
Biological markers of a possible carcinogenic or mutagenic effect of nitrous oxide also have been reported in the literature. Sardas (1992) found elevated sister chromatic exchange frequencies in operating room personnel when compared to controls. A correlation of .596 was reported for the duration of occupational exposure to nitrous oxide and the mean number of sister chromatic exchanges. Urinary thioethers have been detected in personnel with high exposure in the operating room with no or defective scavenger systems (Pasquini, 1989) .
OccupaHonalExposure
Waste gas has been found in high concentrations, even in operating rooms with scavenging systems. Highest levels are commonly found between gas machines and adjacent walls, and along the perimeter of patient drapes and around patient mouths. Canadian researchers found that in three of seven hospitals studied, the mean nitrous oxide exposures were at or exceeded the NIOSH recommendation of 25 ppm (Sass-Kortsak, 1992) . In the sample of individual anesthetists, 27% of the time weighted average (TWA) exposures exceeded the standard, and 14% of the samples from nurses exceeded the standard. Researchers from NIOSH also have measured nitrous oxide exposure as high as 12 times the NIOSH recommended limit in hospital operating rooms and more than 40 times the NIOSH recommended limit in dental operating rooms (NIOSH, 1994) .
These elevated levels demonstrate that use of a scavenger system is not sufficient; it must be continuously monitored and maintained to effectively reduce exposure to nitrous oxide. The most common leaks are: hose connections, disposable breathing circuits, ventilators, pop off valves, and vaporizers; insufficiently inflated endotracheal tube cuffs; poorly fitted patient face masks; gas flow turned on before placing mask on patient; and vaporizers refilled in the "on" position.
In 1977, NIOSH recommended that nitrous oxide be controlled to an 8 hour TWA of 25 ppm, and halogenated agents are not to exceed .5 ppm when combined with nitrous oxide or below 2 ppm when used alone. Recommendations to decrease exposure include effective scavenging vacuum lines to maintain a flow rate of 440 ppm and ventilation of 20 room changes per hour. Equipment checks and environmental monitoring should be conducted every 3 months.
Currently no Occupational Safety and Health Administration (OSHA) requirements for medical surveillance exist. NIOSH recommends informing workers of potential risk; including medical histories with family genetic, reproductive, and occupational histories on file; and obtaining baseline data on the hepatic, renal, and hematopoietic system. Periodic liver and kidney function tests should be done. DECEMBER 1995, VOL. 43, NO. 12 
ETHYLENE OXIDE
Ethylene oxide is a gas widely used by health care workers to sterilize medical supplies that cannot be subjected to the heat of steam. It is a colorless gas with a distinctive sweet, ether like odor. As many as 100,000 health care workers in the United States may be exposed, primarily in central supply, surgical units, and dental offices. Ethylene oxide is an alkylating agent that binds to DNA and may cause cellular mutation.
Ethylene oxide has been found to be carcinogenic and mutagenic in animal studies. A 1982 report described potential reproductive effects in hospital staff engaged in sterilizing instruments with ethylene oxide (Hemminki, 1982) . The frequency of spontaneous abortions in sterilizing staff was 11.3% compared to 10.6% in controls. Staff with exposure during pregnancy had a spontaneous abortion rate of 16.7% compared to 5.6% in staff with no exposure during pregnancy. Increased chromosomal abnormalities also have been reported in exposed workers (Thiess, 1981) .
In health care settings, occupational exposure occurs primarily in the operation of sterilization equipment. Greatest potential for exposure occurs during loading and unloading the sterilizers, transferring freshly sterilized items to an aeration cabinet and changing the tanks, as well as at the gas discharge point.
Ethylene oxide is regulated by OSHA as a carcinogen. OSHA allows 1 ppm maximum exposure for a TWA over 8 hours. However, due to the nature of the exposure, short term exposure limits are of major importance. For example, workers with a 1 ppm TWA could be exposed to 480 ppm for 1 minute in the process of opening a sterilizer door. The actual working condition around sterilizers consists of quick, concentrated bursts of ethylene oxide when the door of the sterilizing machine is opened. Studies reveal that rodents exposed to high doses of ethylene oxide over shorter time periods have more chromosomal breakage and increased fetal mortality (Generoso, 1986) .
Three types of environmental monitoring are generally used: direct reading instruments; activated charcoal samples to determine exposure for an entire day; and passive dosimeters worn by individual workers. Engineering controls include enclosing the sterilizer and exhausting to a dedicated ventilation system. Access to sterilizing rooms should be restricted and units checked at least every 3 months with infrared analyzers and detection sensors for leaks or ventilation failure. The number of exhaust cycles recommended by manufacturers should be completed before the door of the sterilizer is opened, and workers should use protective gloves and goggles when changing supply cylinders. No respirator is necessary if good engineering controls are used.
Protective gloves and gowns should be worn when removing items from the sterilizer. Aeration cabinets are to be used for sterilized supplies. A respirator should be available for emergency situations.
Worker monitoring includes pre-employment baseline testing of the eyes, skin, blood, and respiratory tract. Periodic examinations of skin, eyes, and respiratory, neurologic, and reproductive systems are indicated. 
Teratogenicity and Embryo Toxicity of Antineoplastic Agents

ANTINEOPLASTIC DRUGS
Antineoplastic drugs is a term used to describe the multiple classes of drugs used in the treatment of persons with cancer. The largest occupational group at risk for potential significant exposure is health care workers who mix and administer these drugs. Cancer drugs act by arresting DNA replication, protein synthesis, and mitosis.
Many antineoplastic drugs can be mutagenic, teratogenic, and carcinogenic in experimental systems (See Table 1 ). Increased chromosomal aberrations, sister chromatic exchanges, and DNA single strand breaks have been found in nurses handling the drugs with minimal or no protective equipment (Falck, 1979 : Norppa, 1980 Milkovic-Kraus, 1991; Reitz, 1993) . Reproductive effects have been documented largely with case reports of persons treated with the drugs. Both males and females treated with the drugs can experience effects on reproductive capacity, including reduced fertility, sterility, cessation of menses, and amenorrhea. Virtually all of 
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Adaptedjrom Sorsa (1985) . these agents have some embryo-fetal toxicity, including congenital abnormalities and spontaneous abortions, One Scandinavian epidemiologic study noted that first trimester work exposure to antineoplastic drugs was significantly more common in nurses who gave birth to infants with congenital malformations than among nurses who gave birth to normal infants (Hemminki, 1982) . Selevan (1985) reported an association between exposure in the first trimester of pregnancy and increased fetal loss.
Embryo
Primary routes of exposure are inhalation and skin absorption. Exposure can occur outside of verticallaminar flow hoods used to prepare the drugs and with improper use of personal protective clothing. Aerosol generation can occur when mixing drugs or working with the syringes used to administer the drugs. Splattering and spills also can occur. Leakages are possible from tubing and connections in intravenous administration. Contamination is also possible from exposure to body fluids of persons receiving the drugs.
OSHA (1986) has issued comprehensive guidelines covering staff training and surveillance; use and care of protective equipment, apparel, and techniques; and storage, disposal, and transport of drugs and contaminated equipment. Glove thickness and leakage potential is of concern. Research in the past 5 years has focused on assessing the effectiveness of the protective equipment.
Prevention strategies include the use of vertical laminar air flow hoods, protective gowns and gloves when mixing and administrating, and special handling techniques to decrease the likelihood of spills, skin and aerosol contamination, and environmental contamination. OSHA requires that workers be informed of potential hazards and recommends a medical surveillance program including a preplacement physical examination and a complete blood count. According to OSHA recommendations, alternative duties should be made available to workers actively trying to conceive or breast feeding.
No reliable measures of environmental exposure are currently available. Some work has been published on environmental contamination of specific chemicals in limited workspaces and the detection of specific drugs in the urine of health care workers (Sessink, 1992) No practical method of biological monitoring of exposure exists. Thirlinger (1991) compared methods for the biomonitoring of nurses, comparing urinary mutagenicity, thioethers and sister chromatic exchanges, and micronuclei in peripheral lymphocytes. Mutagenicity may be the most sensitive test. Sister chromatic exchanges is also a viable test, but changes cannot be attributed to present or past exposures. Often a dose response is not evident in these measures. Also, and most importantly, these measures have limited practicality in individual surveillance because of high inter-and intra-individual variability.
RIBAVIRIN AEROSOL
Over 5 million persons have been treated with this antiviral drug, approved in 1986 for the treatment of respiratory syncytical virus in highly compromised infants and young children. Pediatric nurses and respiratory therapists are most likely to be exposed. In 1988, an estimat-ed 50,000 workers were exposed to ribavirin. Ribavirin is a nucleic acid synthesis inhibitor. It affects both RNA and DNA synthesis, thus effectively inhibiting viral synthesis.
Animal studies have demonstrated ribavirin to be teratogenic and/or embryo lethal in nearly all animal species tested by oral administration. Given the method of administration, the potential for absorption by health care workers is of concern. Once absorbed by the body, the drug accumulates in red blood cells, with a half life of 28 days. The possibility of a risk to the fetus of pregnant health care workers is of potential concern. However, insufficient data are available to permit either quantification of the magnitude of this risk or dismissal of its clinical importance.
Ribavirin is administered as an inhaled aerosol mist. The white powder is reconstituted with sterile water and placed in the reservoir of a small particle aerosol generator. The drug can then be delivered to the patient by passive or ventilator systems. Typically a patient is treated for 18 hours per day for 3 to 7 days. If no containment system is used, the excess aerosol is typically exhausted directly into the treatment room. The drug can then be released through leakage from hoods and canopies, through disconnection of the device, patient exhalation, and incomplete exhaust ventilation.
The amount of exposure to workers depends on the amount of time spent in the treatment room, number of children receiving treatments in the same room, route of administration, treatment room ventilation, personal protective equipment, exhaust scavenger devices, and number of treatments the worker is involved with each year. A national survey by Cohen (1992) found that half of the major pediatric medical centers administrating ribavirin did not use scavenging units. Arnold (1993) reviewed studies reporting TWA exposures and room air concentrations of ribavirin. The average health care worker's personal breathing zone air concentration was 266 mg/m". By contrast, with controlled administration, the average was 20 mg/m", In studies conducting biological monitoring of worker urine, serum, and red blood cells, ribavirin was detected in only one red blood cell sample at a concentration of .44 mg/mL in a nurse exposed to air concentration of 316 mg/m'' for 8 hours (Harrison, 1988) .
The following guidelines are useful in minimizing exposure to health care workers and other individuals who may enter rooms where ribavirin is administered. contact with the drug (aerosol preparation and patient care during aerosolization). • Exclusion of pregnant and lactating women and persons with previous reactions to ribavirin from contact with the drug. • Provision of information on ribavirin administration and possible hazards to all staff and visitors to the room.
IONIZING RADIATION
In the United States, natural radiation results in an estimated average dose of about 300 mrem each year. In addition, dental and medical irradiation of patients produces an additional average dose of 50 to 70 mrem per person per year. Health care workers, with 267,000 exposed, comprise the largest proportion of all exposed workers. Ionizing radiation includes x-rays, fluoroscopies, radioactive isotopes, and radioactive implants.
Ionizing radiation consists of the transmission of energy capable of displacing electrons, resulting in the formation of electrically charged ions in matter. Alteration and destruction of DNA is possible. Radiation can cause gene mutation and chromosomal alteration, delay or impair cell division, and interfere with metabolic processes. Rapidly dividing cells are usually more severely affected, including gonadal cells. Exposure to ionizing radiation has been shown to cause congenital abnormalities and cancer in non-occupational studies.
Ionizing radiation can be toxic to both male and female fertility. Radiation induced mutations resulting in genetic effects are possible and prenatal radiation exposure may result in prenatal death or morphologic abnormalities of the developing nervous system or other organ systems and carcinogenic risk to embryo.
The exposures in health care settings are far below those expected to affect ovarian or testicular function. The average work related dose for radiation workers is 260 to 540 mrem per year. The current occupational limit for ionizing radiation exposure to the whole body is 50 mSv (5000 mrem)/year. The Nuclear Regulatory Commission (NRC) and the Environmental Protection Agency (EPA) stipulate that the total dose to embryofetus due to occupational exposure should not exceed 500 mrem (Nuclear Regulatory Commission, 1991) . Once a pregnancy is recognized the National Council on Radiation Protection and Measurement (NCRP) recommends that occupational exposure to the conceptus should not exceed 0.5 mSv (50 mrem) in anyone gestational month (National Council on Radiation, 1987).
Occupational exposure usually results from the scatter of x-ray beams or the emission of gamma rays by patients who are being treated with radio nuclides or implants. Staff in departments where portable x-rays are taken (operating rooms, emergency rooms, or intensive care units) are often inadvertently exposed and may be inadequately monitored.
Major areas of protection include reducing needed doses for therapeutic purposes, limiting time of exposure, and shielding the source. Dosimeters should be worn by all personnel exposed to sources of ionizing radiation. All radiation workers should have preplacement and periodic examinations, including complete blood counts and differential white blood cell tests, eye examinations, history of previous radiation exposure, and reproductive history.
NON-IONIZING RADIATION
Non-ionizing radiation does not have enough energy to ionize atoms, but it vibrates and rotates molecules, causing heat. Different types of non-ionizing radiation are classified by frequency units of hertz and can include ultraviolet, visible (lasers), infrared, radio frequency/microwave, and ultrasound. Table 2 describes the common types of non-ionizing radiation and associated health effects. In recent years the toxic effects of non-ionizing radiation has been a frequent topic of public and scientific debate.
The biological effect of non-ionizing radiation is attributable to cellular heating. Non-thermal biological responses are currently being investigated. The testes and the developing embryo are vulnerable to the thermal effects of radio frequency/microwave radiation. The biological effect on the embryo may include loss of ionized calcium from nerve membranes, altered permeability of cells, alteration of the blood-brain barrier, and alteration in 618 cell metabolism and proliferation. A recent study by NIOSH on the reproductive effects of occupational exposure to video display terminals failed to demonstrate a toxic reproductive effect (Schnorr, 1991) .Animal studies of the effects of magnetic resonance imaging (MRI) on reproductive potential have been conflicting (Brent, 1993) .
The usual industrial and environmental exposures to radio frequency radiation are well below thresholds for induction of developmental effects related to heat. Recommendations of occupational exposure is .4 watts per kilogram (wlkg) for radio frequencies between 300 kHz and 100 GHz. The best control is through protective screening of the source. At this time there are no reproductive data that support the need to protect health care workers from the non-ionizing radiation emitted from microwaves, video display terminals, MRI, or ultrasound.
BIOLOGICAL AGENTS
Perhaps infectious agents are the most closely studied agents found in health care settings with the potential of reproductive effects. For the past 2 decades, health care workers have been aware of the need to isolate and protect Table 3 shows the common viral agents associated with reproductive effects. The rubella virus can cause spontaneous abortion, stillbirth, and congenital defects in the offspring of infected women. Approximately 10% to 20% of childbearing aged women are susceptible to the virus. Infants with congenital rubella syndrome can shed the virus for 1 year or longer. In adults, 25% to 50% of all cases are asymptomatic, but intrauterine transmission of the virus can be catastrophic. Congenital rubella syndrome is characterized by intrauterine growth retardation, hearing and vision deficits, and neurologic and cardiac abnormalities.
Rubella vaccination of all women of childbearing age who are not pregnant or immune suppressed is strongly recommended (Advisory Committee on Immunization Practices, 1987). Patients with congenital rubella syndrome who are actively secreting the virus need isolation.
Human parvovirus B19 (HPV) is a DNA virus causing Fifth's disease or erythema infectiosum. This disease, commonly occurring in school aged children, is characterized by fever, flu like illness, and a rash on the face with generalized exanthem on the trunk and extremities. The disease may cause transient aplastic crisis in some persons. Infection during pregnancy has resulted in fetal loss and nonimmune hydrops fetalis. Data suggest that the risk of fetal death secondary to HPV B19 infection is between 1.5% to 5%. The antibody is present in 5% to 10% of school age children and 50% of adults.
Attack rates of 36% have occurred among susceptible health care workers during nosocomial outbreaks of HPY. No vaccine is available, and patients should be isolated for duration of the illness. Masks are recommended for caring for these patients. Pregnant women should be excluded from caring from patients with aplastic anemia crisis.
Hepatitis B is the most frequent nosocomial infection among health care workers. In a 1992 investigation of 797 Swedish health care workers, Struve (1992) found that 3.9% were positive for at least one marker of hepati- DECEMBER 1995, VOL. 43, NO. 12 tis B virus (HBV). The prevalence of HBV markers increased with age and duration of occupation in health care. Workers with HBV markers were more likely to report a history of exposure to needlestick injuries than workers without such markers.
Reproductive effects of HBV infection include preterm delivery and transmission to fetus. Infants may develop acute hepatitis, chronic hepatitis, and fulminant disease. The HBV can be cultured in the blood, urine, saliva, feces, semen, vaginal secretions, bile, amniotic fluid, and breast milk. A vaccine is available and effective in 90% of healthy recipients. Protection lasts for at least 5 to 8 years. The need and timing of a "secondary" booster is undetermined. All pregnant women should be tested for immune status, and the vaccine is not contraindicated during pregnancy.
OSHA mandates that employers offer the HBV vaccine to susceptible workers at significant risk for infection and at no cost to the worker (US. Department of Labor, 1991) . After a needlestick injury, ifthe worker is susceptible and the potential source is positive, the Immunization Practices Advisory Committee recommends administration of hepatitis B immune globulin as soon as possible and initiation of the vaccine series (Centers for Disease Control and Prevention [CDC], 1991a). All workers are strongly encouraged to practice universal precautions.
Cytomegalovirus (CMV) is a DNA virus with the highest incidence of in-utero transmission. Rates of seropositivity approach 100% in developing countries. High risk workers include nurses, especially in pediatric settings, and laboratory personnel. Approximately 30,000 infants are born with CMV infection each year in the United States. Ninety percent are asymptomatic. Symptomatic infants are at risk for macrocephaly, microcephaly, microphthalmia, cataracts, developmental impairment, and hearing deficits. The fatality rate in infected infants is 20%. The relationship between gestational age and the time of in-utero transmission is not clear.
The CMV virus can be cultured in urine, saliva, tears, cervical secretions, breast milk, blood, semen, and feces. Infections during pregnancy are usually asymptomatic. Currently no vaccine is available, but studies are in progress. Pregnant workers should be informed of risk. Good personal hygiene is of extreme importance, along with the use of universal precautions when caring for patients with CMV. Varicella zoster is a DNA virus causing chickenpox and shingles or herpes zoster. Transmission to the fetus can cause varicella embryopathy and varicella of the newborn. Chickenpox is an uncommon disease in pregnancy. Most adults in temperate climates are immune. However, with the recent influx of young adults from tropical countries into the United States, the incidence of varicella susceptible adults appears to be increasing (Gray, 1990) . The health care worker's susceptibility to varicella zoster virus varies from 2.9% to 18%, with susceptibility being age and climate dependent. Fetal effects may include low birth weight, neurologic symptoms, cataracts, limb deformities, and skin lesions.
A varicella zoster vaccine has recently been developed, and recommendations for the use of the vaccine in children and adolescents have been published (American Academy of Pediatrics, 1995) . Recommendations for adult vaccine use are being addressed by the CDC Advisory Committee on Immunization Practices. The vaccine is contraindicated in pregnancy. Pregnant women without a history of infection or serologic evidence of immunity should avoid contact with infected individuals.
Herpes simplex is the most frequently identified work related viral skin infection in the United States. Health care workers, especially those with exposure to mucus secretions, may develop the infection. In addition, a large number of persons in the general population are infected with the virus and suffer from periodic episodes of vesicular skin eruptions. Susceptible, pregnant health care workers should be informed of the evidence of increased rates of spontaneous abortion in infected pregnant women. Also, herpes simplex can cause microcephaly, microphthalmia, and retinal dysplasia in the offspring of infected mothers. Health care workers with active herpes lesions should have restricted patient contact.
The World Health Organization (WHO) estimates that 8 to 10 million adults and 1 million children worldwide are infected with human immunodeficiency virus (HIV) (CDC, 1991b) . Health care workers who come into direct contact with infected biological fluids at their jobs risk exposure to mv. As of September 30, 1992, the CDC had received reports of 32 health care workers with documented occupationally acquired HfV infection and 69 with possible occupationally acquired HfV infection. The majority of these workers were nurses and clinical laboratory technicians. Sources of infection include accidental skin penetration by needles or sharps contaminated with infected body fluids and open lesion contact with infected body fluids.
Maternal transmission to the fetus occurs via transplacental passage, perinatal contact with infected maternal blood, and breast milk. Between 25% to 50% of infants born to HIV positive mothers will contract the infection.
Symptomatic maternal infection and CD4 lymphocyte depletion may be risk factors for perinatal transmission.
Studies have shown that pregnant women who care for HIV infected patients are not known to be at greater risk for acquiring HIV than their nonpregnant coworkers. As in any situation involving the care of a person with potential bloodborne infection, strict adherence to universal precautions established by CDC and the OSHA bloodborne pathogens standard is necessary. Pregnant workers should be aware that HIV, immune suppressed patients are more susceptible to infections such as CMV and toxoplasmosis, and appropriate protective practices must be used.
SUMMARY
It is evident that reproductive issues will continue to be a major issue in occupational health and health care settings. Occupational health professionals need to have current information about known or suspected toxicologic effects. Most important, occupational health nurses should be aware that the reproductive safety of agents in the workplace is seldom established before they are used in work settings. Our knowledge of the risk of exposure to potential toxic agents is based on a combination of laboratory research and all too infrequent epidemiologic studies. The occupational health nurse will often provide updated information on reproductive toxins and also counseling to individual health care workers about work practice and reproductive risks.
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Anesthetic gases, particularly nitrous oxide, have been investigated for potential reproductive, mutagenic, and carcinogenic effects. Waste gases have been found in high concentrations, even with work settings with scavenger systems in place.
Antineoplastic drugs, commonly used to treat persons with cancer, are virtually all considered to be embryo-fetal toxic. OSHA has issued comprehensive guidelines covering staff training, handling practices, and use of protective equipment.
The toxic effect of non-ionizing radiation has been a frequent topic of public and scientific debate. At this time no evidence exists of a reproductive hazard to health care workers.
Biologic agents such as rubella, hepatitis, cytomegalovirus, varicella, and human immunodeficiency virus frequently have the potential for adverse effects on the fetus. Administration of a vaccine or care of patients with active infection may be contraindicated in pregnancy.
